Standard Family Office’s Exelixis EXEL Stock Holding History

Standard Family Office’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-44	Closed	-$1K	–	232
2021 Q2	$1K	Hold	44	–	–	﹤0.01%	491
2021 Q1	$1K	Buy	+44	New	+$994	﹤0.01%	523

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Standard Family Office's EXEL Position: Q3 2021 in Review

Standard Family Office sold out of Exelixis (EXEL) in Q3 2021, closing a stake of 44 shares — an estimated $1K sold.

Standard Family Office first reported a position in EXEL in Q1 2021 and held it in 2 quarters. The position peaked at $1K in Q2 2021. 339 funds tracked by Wall St. Rank hold EXEL as of Q3 2021.

Standard Family Office reported no remaining Exelixis position as of Q3 2021 after selling out during the quarter.
Standard Family Office sold 44 Exelixis shares in Q3 2021, an estimated $1K.
Standard Family Office first reported a position in Exelixis in Q1 2021 and held it in 2 quarters.
Standard Family Office's Exelixis position peaked at $1K in Q2 2021.
339 funds tracked by Wall St. Rank held Exelixis as of Q3 2021.

Based on Standard Family Office's 13F filing for Q3 2021, filed 15 Nov 2021.